261 related articles for article (PubMed ID: 15618188)
1. CXCR3 and its ligands participate in the host response to Bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lung.
Widney DP; Hu Y; Foreman-Wykert AK; Bui KC; Nguyen TT; Lu B; Gerard C; Miller JF; Smith JB
Infect Immun; 2005 Jan; 73(1):485-93. PubMed ID: 15618188
[TBL] [Abstract][Full Text] [Related]
2. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM
J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412
[TBL] [Abstract][Full Text] [Related]
3. Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome.
Hildebrandt GC; Corrion LA; Olkiewicz KM; Lu B; Lowler K; Duffner UA; Moore BB; Kuziel WA; Liu C; Cooke KR
J Immunol; 2004 Aug; 173(3):2050-9. PubMed ID: 15265940
[TBL] [Abstract][Full Text] [Related]
4. CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages.
Nishioka Y; Manabe K; Kishi J; Wang W; Inayama M; Azuma M; Sone S
Clin Exp Immunol; 2007 Aug; 149(2):317-26. PubMed ID: 17550373
[TBL] [Abstract][Full Text] [Related]
5. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
[TBL] [Abstract][Full Text] [Related]
6. CXCR3, IP-10, and Mig are required for CD4+ T cell recruitment during the DTH response to HSV-1 yet are independent of the mechanism for viral clearance.
Molesworth-Kenyon S; Mates A; Yin R; Strieter R; Oakes J; Lausch R
Virology; 2005 Mar; 333(1):1-9. PubMed ID: 15708587
[TBL] [Abstract][Full Text] [Related]
7. CXCR3 and its ligands in a murine model of obliterative bronchiolitis: regulation and function.
Medoff BD; Wain JC; Seung E; Jackobek R; Means TK; Ginns LC; Farber JM; Luster AD
J Immunol; 2006 Jun; 176(11):7087-95. PubMed ID: 16709871
[TBL] [Abstract][Full Text] [Related]
8. CXC chemokines IP-10 and mig expression and direct migration of pulmonary CD8+/CXCR3+ T cells in the lungs of patients with HIV infection and T-cell alveolitis.
Agostini C; Facco M; Siviero M; Carollo D; Galvan S; Cattelan AM; Zambello R; Trentin L; Semenzato G
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1466-73. PubMed ID: 11029363
[TBL] [Abstract][Full Text] [Related]
9. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.
Ranjbaran H; Wang Y; Manes TD; Yakimov AO; Akhtar S; Kluger MS; Pober JS; Tellides G
Circulation; 2006 Sep; 114(12):1293-300. PubMed ID: 16940188
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation.
Xanthou G; Williams TJ; Pease JE
Eur J Immunol; 2003 Oct; 33(10):2927-36. PubMed ID: 14515277
[TBL] [Abstract][Full Text] [Related]
11. CXCR3 and IFN protein-10 in Pneumocystis pneumonia.
McAllister F; Ruan S; Steele C; Zheng M; McKinley L; Ulrich L; Marrero L; Shellito JE; Kolls JK
J Immunol; 2006 Aug; 177(3):1846-54. PubMed ID: 16849496
[TBL] [Abstract][Full Text] [Related]
12. Effects of CXCR3 signaling on development of fatal encephalitis and corneal and periocular skin disease in HSV-infected mice are mouse-strain dependent.
Lundberg P; Openshaw H; Wang M; Yang HJ; Cantin E
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4162-70. PubMed ID: 17724202
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
14. Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states.
Cox MA; Jenh CH; Gonsiorek W; Fine J; Narula SK; Zavodny PJ; Hipkin RW
Mol Pharmacol; 2001 Apr; 59(4):707-15. PubMed ID: 11259614
[TBL] [Abstract][Full Text] [Related]
15. CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma.
Jinquan T; Jing C; Jacobi HH; Reimert CM; Millner A; Quan S; Hansen JB; Dissing S; Malling HJ; Skov PS; Poulsen LK
J Immunol; 2000 Aug; 165(3):1548-56. PubMed ID: 10903763
[TBL] [Abstract][Full Text] [Related]
16. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils.
Gasperini S; Marchi M; Calzetti F; Laudanna C; Vicentini L; Olsen H; Murphy M; Liao F; Farber J; Cassatella MA
J Immunol; 1999 Apr; 162(8):4928-37. PubMed ID: 10202039
[TBL] [Abstract][Full Text] [Related]
17. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.
Romagnani P; Rotondi M; Lazzeri E; Lasagni L; Francalanci M; Buonamano A; Milani S; Vitti P; Chiovato L; Tonacchera M; Bellastella A; Serio M
Am J Pathol; 2002 Jul; 161(1):195-206. PubMed ID: 12107104
[TBL] [Abstract][Full Text] [Related]
18. Regulation of pulmonary fibrosis by chemokine receptor CXCR3.
Jiang D; Liang J; Hodge J; Lu B; Zhu Z; Yu S; Fan J; Gao Y; Yin Z; Homer R; Gerard C; Noble PW
J Clin Invest; 2004 Jul; 114(2):291-9. PubMed ID: 15254596
[TBL] [Abstract][Full Text] [Related]
19. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
Proost P; Schutyser E; Menten P; Struyf S; Wuyts A; Opdenakker G; Detheux M; Parmentier M; Durinx C; Lambeir AM; Neyts J; Liekens S; Maudgal PC; Billiau A; Van Damme J
Blood; 2001 Dec; 98(13):3554-61. PubMed ID: 11739156
[TBL] [Abstract][Full Text] [Related]
20. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
